Researchers at Argonne National Laboratory analyze reactive molecules generated during electrocatalysis to better understand how electricity-driven processes can break down persistent water pollutants Modern society relies on thousands of synthetic chemicals that improve everyday life, from vibrant textile dyes to…
Modular Genetics partners with the New American Industrial Alliance to accelerate advanced biomanufacturing and strengthen U.S. techno-industrial leadership. Modular Genetics, Inc., a pioneering company in the field of Industrial Biotechnology, has announced that it has officially joined the New American…
Enterprise Products Partners Shares 2025 Investor Letter Highlighting Strategic Growth, Market Outlook, and Operational Performance. Enterprise Products Partners L.P. has released its 2025 Letter to Investors, providing stakeholders with insights into the partnership’s operational performance, strategic priorities, and long-term outlook.…
Orion S.A. Sets June 25, 2026, for Annual General Meeting and Confirms Shareholder Record Date. Orion S.A., a global specialty chemicals company listed on the New York Stock Exchange under the ticker OEC, has announced the date and details for…
MindWalk Introduces B Cell Llama™ to Accelerate Nanobody Discovery for Next-Generation Therapies MindWalk Holdings Corp a bio-native artificial intelligence company focused on advanced drug discovery, has announced the launch of B Cell Llama™, a specialized platform designed to discover VHH…
LabVantage Solutions has introduced a new artificial intelligence–driven platform designed to transform how laboratories manage data, workflows, and automation. The company announced the launch of LabVantage CORTEX, a next-generation platform that combines artificial intelligence (AI), advanced analytics, and automation technologies…
Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…
Vertex Pharmaceuticals Announces Phase 4 Data Demonstrating JOURNAVX® Enables Opioid-Free Recovery Following Aesthetic and Reconstructive Procedures Vertex Pharmaceuticals Incorporated today announced new data from a Phase 4 study evaluating JOURNAVX® (suzetrigine), a prescription non-opioid pain signal inhibitor, for the management…
Four Innovative Companies Join Halliburton Labs to Accelerate Energy and Materials Solutions Halliburton Labs has announced the addition of four pioneering companies—Nandina REM, Noon Energy, Proof Energy, and Tidal Metals—to its growing community of early-stage innovators. These companies join a…
Bloomfire Partners with Worley Consulting to Transform Knowledge Management in Energy, Chemicals, and Resources Sectors Bloomfire has announced a strategic partnership with Worley Consulting, a leading provider of advisory solutions across the energy, chemicals, and resources sectors. The collaboration will…
Modular Genetics, Inc. Joins New American Industrial Alliance to Drive U.S. Reindustrialization Modular Genetics, Inc. (Modular), a leading Industrial Biotechnology company, is proud to announce its membership in the New American Industrial Alliance (NAIA), a move that positions the company…
BioMed Realty and CordenPharma Colorado Expand Peptide Development Capacity with New Facility in Boulder BioMed Realty, a leading private owner and operator of real estate dedicated to the life sciences, technology, and innovation sectors, has announced a major new partnership…